Browsing: Commentary
Guest commentary articles from industry experts from across the longevity and mortality markets. If you would like to submit an article for consideration for publishing by Longevity and Mortality Investor, please click here.
As we enter the 4th year of the COVID-19 pandemic and as the number of infected survivors grows ever larger,…
It’s not unrealistic for institutional, end investors to expect – and receive – double digit IRRs from their allocations to…
The option to sell one’s life insurance policy in the life settlement market is an attractive one. Whether individuals need…
The climate crisis has both direct and indirect impacts on human health, and we stand at a dire crossroads in terms of human health
Interest in the life settlement asset class, the purchase of an unwanted and unneeded life insurance policy for a lump…
The Covid-19 pandemic has caused a dramatic shock to health and life expectancy, disrupting the pattern of mortality improvement seen…
Celent’s Rob Norris offers his views on terminology in the insurtech market and what he real technology to emphasise is
Actuarial Risk Management’s Cory Zass looks at what 2023 might have in store for the life settlement market
The concept of a life settlement investment is quite simple: the collected death benefits must exceed the cost (purchase price,…
In the past 40 years, life expectancy has increased significantly as a result of a range of factors, including advancements…